Advancing Brain Tumor Care: Insights from Dr. Nader Sanai, Emily McIntosh & Dr. Alireza Mansouri
Join WeTrials for an inspiring and insightful conversation featuring Dr. Nader Sanai, Director of the Ivy Brain Tumor Center and Chief of Neurosurgical Oncology at Barrow Neurological Institute, and Emily McIntosh, a resilient patient advocate and clinical researcher. Hosted by Dr. Alireza Mansouri, this episode dives deep into the groundbreaking advancements in brain tumor research, the transformative power of clinical trials, and the unwavering hope driving the future of neuro-oncology.
Discover how early-phase trials, personalized medicine, and novel drug development are paving the way for better patient outcomes. Learn about the logistics of participating in window-of-opportunity trials, the critical role of genomic data, and the importance of supporting patients across borders. Emily McIntosh also shares her inspiring journey of resilience and hope after undergoing two brain surgeries.
🔗 Key Topics Covered:
- The evolution of clinical trials and their impact on brain tumor research
- The promise of early-phase trials and breakthrough discoveries like Niraparib
- Personalized medicine and genomic data in glioblastoma treatment
- Stories of resilience and hope for patients and their families
🎧 Whether you’re a healthcare professional, a patient, or someone passionate about innovation in medicine, this podcast is a must-listen for insights into the ever-evolving world of brain tumor care.
Subscribe and listen now to stay informed and inspired!
Leave a Reply